Moonlight Bio
- Business Model
- B2B
- Website
- moonlightbio.us
- Last Round
- SeedJan 2023
- Rounds
- 1
About
Moonlight Bio is a biotech company developing T cell therapies for cancer patients by harnessing evolutionary forces to achieve unparalleled advances in T cell potency. The company is collaborating with partners such as Biocytogen to advance its cell therapy pipeline using libraries of antibody binders, aiming for unrivaled clinical outcomes in cancer treatment.
Summary
Moonlight Bio is a Biotech company based in United States. Its most recent funding was a Seed round in Jan 2023. Investors include ARCH Venture Partners, Venrock and Parker Institute for Cancer Immunotherapy.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2023
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/moonlight-bio"><img src="https://indexed.vc/api/badge/company/moonlight-bio" alt="Moonlight Bio on Indexed.vc" width="260" height="76" /></a>